CLAIM CARD
We conducted an AI-assisted structured evidence synthesis, systematically screening and adjudicating 51 curated reference documents with an auditable decision trail to evaluate whether PCSK9 inhibition modifies hard mortality, surrogate aging biomarkers, or safety signals relevant to long-term healthspan.
Evidence grade: exploratory
Contradiction status: none
Publication: 4753c82f-24d3-490c-8a23-6cc8d4194c24
Provenance: Derivation Web chain
Citation Support
source_1Ma 2025source_2Schwartz 2021source_3Lehrke 2024source_4Imran 2023source_5Faraidy 2023